---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-010911"
form_type: "8-K"
ticker: "SRXH"
cik: "0001471727"
company_name: "SRx Health Solutions, Inc."
filed_at: "2026-03-18T23:59:59+00:00"
generated_at: "2026-05-15T09:50:54.982708+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# SRx Health Solutions raises up to $8.0M via Series B preferred and warrants; initial close $4.528M

## Summary
- Securities Purchase Agreement for up to 10,000 Series B shares ($1,000 stated value) and warrants at $0.3182 exercise price.
- Initial closing of 5,660 Series B shares and 22,237,666 warrants for gross proceeds of ~$4.528M.
- Warrants expire 3 years from exercisability; exercise price subject to adjustment after stockholder approval.
- Company optional redemption at 125% of greater of stated value or market price; conversion price fixed at $0.3182.

## SEC filing metadata
- accession: 0001493152-26-010911
- form_type: 8-K
- ticker: SRXH
- cik: 0001471727
- company_name: SRx Health Solutions, Inc.
- filed_at: 2026-03-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1471727/000149315226010911/0001493152-26-010911-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1471727/000149315226010911/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-010911
- JSON: https://secwatch.observer/filing/0001493152-26-010911.json
- Plain text: https://secwatch.observer/filing/0001493152-26-010911.txt

## Key facts
- Equity Issuances
  SRx Health Solutions, Inc. issued 22,237,666 Warrants to purchase shares of Common Stock of warrant to accredited investors named therein for aggregate proceeds of approximately $4.528 million, paid in cash.
  - Security: warrant
  - Shares: 22,237,666 Warrants to purchase shares of Common Stock
  - Purchaser: accredited investors named therein
  - Consideration: aggregate proceeds of approximately $4.528 million, paid in cash
  source text: On March 16, 2026 at the initial closing, pursuant to the Securities Purchase Agreement, the Company issued and sold, and certain investors purchased, in a private placement (the “Private Placement”): 5,660 shares of the Series B Preferred Stock and 22,237,666 Warrants to purchase shares of Common Stock for aggregate proceeds of approximately $4.528 million, paid in cash.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1471727/000149315226010911/0001493152-26-010911-index.htm
- Equity Issuances
  SRx Health Solutions, Inc. issued 5,660 shares of the Series B Preferred Stock of preferred stock to accredited investors named therein for aggregate proceeds of approximately $4.528 million, paid in cash.
  - Security: preferred stock
  - Shares: 5,660 shares of the Series B Preferred Stock
  - Purchaser: accredited investors named therein
  - Consideration: aggregate proceeds of approximately $4.528 million, paid in cash
  source text: On March 16, 2026 at the initial closing, pursuant to the Securities Purchase Agreement, the Company issued and sold, and certain investors purchased, in a private placement (the “Private Placement”): 5,660 shares of the Series B Preferred Stock and 22,237,666 Warrants to purchase shares of Common Stock for aggregate proceeds of approximately $4.528 million, paid in cash.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1471727/000149315226010911/0001493152-26-010911-index.htm
- Material Agreements
  SRx Health Solutions, Inc. entered into Securities Purchase Agreement with certain accredited investors named therein valued at up to $8.0 million (effective 2026-03-16).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain accredited investors named therein
  - Value: up to $8.0 million
  - Effective: 2026-03-16
  source text: On March 16, 2026, SRx Health Solutions, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain accredited investors named therein. Pursuant to the Securities Purchase Agreement, up to 10,000 shares of the Company’s Series B convertible preferred stock, par value $0.001 per share (the “Series B Preferred Stock”) and accompanying warrants (“Warrants”) to purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) may be purchased for an aggregate purchase price of up to $8.0 million in one or more closings (each a “Closing”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1471727/000149315226010911/0001493152-26-010911-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.